Ashi Sharukia
Global CFO
Notable Quotes
We expect the EBITDA margins to be in the range of 18.5% to 20%... this guidance does not include any contribution from lanreotide in FY27.
Global CFO
We expect the EBITDA margins to be in the range of 18.5% to 20%... this guidance does not include any contribution from lanreotide in FY27.